UNSPSC 51371805: Ketobemidone hydrochloride

This classification denotes an opioid receptor agonist with the molecular formula C15H21NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U9U6LTV80K, chemically known as 1-propanone, 1-(4-(m-hydroxyphenyl)-1-methyl-4-piperidyl)-, hydrochloride but more generally known as ketobemidone hydrochloride, which bears US NIH Compound Identifier 80069. European Medicines Agency schedules Ketobemidone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02832MIG.

UNSPSC 51371805 Ketobemidone hydrochloride is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS for Naloxone and Safe Drug Deactivation Systems—does not represent ketobemidone procurement but rather naloxone (an opioid antagonist used in overdose reversal) and drug deactivation equipment. This mismatch suggests either a coding error in the source system or that the code is not actively used by state and local buyers for its intended pharmaceutical product line. When state and local procurement activity under a code diverges sharply from the code's definition, the practical opportunity set narrows substantially.

Seminole County, Florida, posted the naloxone procurement as an IFB on June 30, 2026, with a response deadline of July 26, 2023 (an apparent date inconsistency in the source record). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, with an initial two-year contract term and one-year renewal option. All shipping and delivery costs were to be included in vendor pricing. The solicitation required electronic bid submission, E-Verify compliance, drug-free workplace certification, and standard insurance coverage (workers' compensation, commercial general liability, professional liability). No explicit set-aside designations were noted. The absence of additional recent opportunities under this code, combined with the naloxone focus of the single posted opportunity, indicates that buyers pursuing opioid-response supplies are tagging them under codes aligned with naloxone rather than ketobemidone hydrochloride.